A Study of Nasal Glucagon in Participants With a Common Cold
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety of nasal glucagon (NG) in
participants with a common cold, some of whom will also take a nasal decongestant. The study
will investigate how the body processes NG and the effect of NG on the body. The study will
last up to 30 days for each participant.